Quantitative and Qualitative Features of Acute Phase-Adverse Events Following SARS-CoV-2 Vaccination in a Large Sample of People with Multiple Sclerosis

Few data are available on adverse events (AE) associated to vaccines in persons with multiple sclerosis (pwMS).